// App-Quantinova.ai

4711 : Broad anti-tumor activity of a novel BET bromodomain inhibitor

Researchers

Presenter

  • Yan Ma

Principal Investigators

  • Ben Powell

  • Jiazhong Zhang

  • Ying Zhang

  • Heidi Carias

  • Ullrich Schwertschlag

  • Gaston Habets

  • Prabha Ibrahim

  • Wayne Spevak

  • Chao Zhang

  • Gideon Bollag

Medical Centers

  • Plexxikon Inc, Berkeley, CA

Locations

  • United States

Companies

  • Plexxikon Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hematological malignancies

  • Multiple Myeloma

  • Solid malignancies

  • Lymphomas

  • Melanoma

  • Small cell lung cancer

Biomarkers

  • N/A

Drug/Treatment

  • Molibresib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved